Price to Sales (P/S)
since 2005
Paying user area
Try for free
Cigna Group pages available for free this week:
- Balance Sheet: Assets
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common-Size Income Statement
- Analysis of Liquidity Ratios
- Analysis of Reportable Segments
- Present Value of Free Cash Flow to Equity (FCFE)
- Operating Profit Margin since 2005
- Return on Equity (ROE) since 2005
- Return on Assets (ROA) since 2005
- Total Asset Turnover since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Cigna Group for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Cigna Group, P/S, long-term trends, calculation
| P/S | = | Share price1, 2, 3 | ÷ | Sales per share1 | Sales per share1 | = | Revenues from external customers1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2025 | = | ÷ | = | ÷ | |||||||
| Feb 29, 2024 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2023 | = | ÷ | = | ÷ | |||||||
| Feb 24, 2022 | = | ÷ | = | ÷ | |||||||
| Feb 25, 2021 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2020 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2019 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2018 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2017 | = | ÷ | = | ÷ | |||||||
| Feb 25, 2016 | = | ÷ | = | ÷ | |||||||
| Feb 26, 2015 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2014 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2013 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2012 | = | ÷ | = | ÷ | |||||||
| Feb 25, 2011 | = | ÷ | = | ÷ | |||||||
| Feb 25, 2010 | = | ÷ | = | ÷ | |||||||
| Feb 26, 2009 | = | ÷ | = | ÷ | |||||||
| Feb 29, 2008 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2007 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2006 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Cigna Group Annual Report.
- Share Price Trend
- The share price demonstrates considerable volatility over the analyzed period, beginning at $41.32 in early 2006. It experienced a sharp decline to $16.39 by early 2009, likely reflecting broader market or company-specific challenges during this time. Post-2009, the share price showed a notable recovery and sustained growth, reaching a peak of $336.14 in early 2024, before a slight decline to $302.92 in early 2025. This overall upward trend in recent years suggests improved market confidence and potentially strong company performance.
- Sales per Share Analysis
- Sales per share exhibited a general upward trajectory across the timeline. Starting at $42.21 in 2006, sales per share rose fairly steadily with occasional fluctuations, reaching $167.08 by early 2018. There was a temporary dip to $124.11 in 2019, followed by a remarkable surge to $663.92 in early 2024 and further to $899.41 by early 2025. This significant increase in sales per share over the final years indicates substantial revenue growth per share, which may be linked to business expansion, improved operational efficiency, or other positive developments.
- Price-to-Sales (P/S) Ratio Evaluation
- The P/S ratio started close to parity at 0.98 in early 2006 and declined sharply to a low of 0.24 by early 2009, mirroring the decrease in share price and relative undervaluation compared to sales at that time. Subsequently, the ratio trended upwards, climbing to a peak of 1.41 in early 2019, suggesting increasing market valuation relative to sales. Yet, following this peak, the P/S ratio dropped and stabilized in the range of approximately 0.34 to 0.51 during 2023 to 2025, despite rising sales per share and share prices continuing their recovery and growth. This may indicate that market valuation has become more conservative relative to sales growth in the most recent years or that sales growth has outpaced share price appreciation.
- Overall Insights
- The data indicates a period of initial instability marked by a significant share price decline and low P/S ratios during the late 2000s, likely reflecting adverse economic or company-specific conditions. From around 2010 onward, a sustained positive trend emerges with growth in share price and sales per share, although the P/S ratio suggests periods of varying market valuation sentiment. The dramatic increase in sales per share in recent years, coupled with a relatively moderate P/S ratio, may point to an opportunity for further share price appreciation or reflect cautious investor optimism. The slight downturn in share price in 2025, despite record sales per share, also merits further investigation to understand underlying factors. Overall, the company exhibits strong sales growth with some volatility in market valuation metrics across the examined timeframe.
Comparison to Competitors
Cigna Group, P/S, long-term trends, comparison to competitors
| Cigna Group | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Feb 27, 2025 | ||||||
| Feb 29, 2024 | ||||||
| Feb 23, 2023 | ||||||
| Feb 24, 2022 | ||||||
| Feb 25, 2021 | ||||||
| Feb 27, 2020 | ||||||
| Feb 28, 2019 | ||||||
| Feb 28, 2018 | ||||||
| Feb 23, 2017 | ||||||
| Feb 25, 2016 | ||||||
| Feb 26, 2015 | ||||||
| Feb 27, 2014 | ||||||
| Feb 28, 2013 | ||||||
| Feb 23, 2012 | ||||||
| Feb 25, 2011 | ||||||
| Feb 25, 2010 | ||||||
| Feb 26, 2009 | ||||||
| Feb 29, 2008 | ||||||
| Feb 28, 2007 | ||||||
| Feb 23, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Cigna Group, P/S, long-term trends, comparison to sector (health care equipment & services)
| Cigna Group | Health Care Equipment & Services | |
|---|---|---|
| Feb 27, 2025 | ||
| Feb 29, 2024 | ||
| Feb 23, 2023 | ||
| Feb 24, 2022 | ||
| Feb 25, 2021 | ||
| Feb 27, 2020 | ||
| Feb 28, 2019 | ||
| Feb 28, 2018 | ||
| Feb 23, 2017 | ||
| Feb 25, 2016 | ||
| Feb 26, 2015 | ||
| Feb 27, 2014 | ||
| Feb 28, 2013 | ||
| Feb 23, 2012 | ||
| Feb 25, 2011 | ||
| Feb 25, 2010 | ||
| Feb 26, 2009 | ||
| Feb 29, 2008 | ||
| Feb 28, 2007 | ||
| Feb 23, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Cigna Group, P/S, long-term trends, comparison to industry (health care)
| Cigna Group | Health Care | |
|---|---|---|
| Feb 27, 2025 | ||
| Feb 29, 2024 | ||
| Feb 23, 2023 | ||
| Feb 24, 2022 | ||
| Feb 25, 2021 | ||
| Feb 27, 2020 | ||
| Feb 28, 2019 | ||
| Feb 28, 2018 | ||
| Feb 23, 2017 | ||
| Feb 25, 2016 | ||
| Feb 26, 2015 | ||
| Feb 27, 2014 | ||
| Feb 28, 2013 | ||
| Feb 23, 2012 | ||
| Feb 25, 2011 | ||
| Feb 25, 2010 | ||
| Feb 26, 2009 | ||
| Feb 29, 2008 | ||
| Feb 28, 2007 | ||
| Feb 23, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).